|
1
|
Gao J, Xie L, Yang WS, Zhang W, Gao S,
Wang J and Xiang YB: Risk factors of hepatocellular
carcinoma-Current status and perspectives. Asian Pac J Cancer Prev.
13:743–752. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hong J, Hu K, Yuan Y, Sang Y, Bu Q, Chen
G, Yang L, Li B, Huang P, Chen D, et al: CHK1 targets spleen
tyrosine kinase (L) for proteolysis in hepatocellular carcinoma. J
Clin Inves. 122:2165–2175. 2012. View
Article : Google Scholar
|
|
5
|
Cha C, Fong Y, Jarnagin WR, Blumgart LH
and DeMatteo RP: Predictors and patterns of recurrence after
resection of hepatocellular carcinoma. J Am Coll Surg. 197:753–758.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bosch FX, Ribes J, Diaz M and Cleries R:
Primary liver cancer: Worldwide incidence and trends.
Gastroenterology. 127:S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zlotnik A and Yoshie O: Chemokines: A new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan A, Chen JJ, Yao PL and Yang PC: The
role of interleukin-8 in cancer cells and microenvironment
interaction. Front Biosci. 10:853–865. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lazennec G and Richmond A: Chemokines and
chemokine receptors: New insights into cancer-related inflammation.
Trends Mol Med. 16:133–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Wang L, Zhang M, Jin M, Bai C and
Wang X: Potential mechanism of interleukin-8 production from lung
cancer cells: An involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J
Cell Physiol. 227:35–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mohamed MM: Monocytes conditioned media
stimulate fibronectin expression and spreading of inflammatory
breast cancer cells in three-dimensional culture: A mechanism
mediated by IL-8 signaling pathway. Cell Commun Signal. 10:32012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ning Y, Labonte MJ, Zhang W, Bohanes PO,
Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli
Venkata KC, et al: The CXCR2 antagonist, SCH-527123, shows
antitumor activity and sensitizes cells to oxaliplatin in
preclinical colon cancer models. Mol Cancer Ther. 11:1353–1364.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Wang W, Wang L, Wang X and Xia J:
Regulatory mechanisms of interleukin-8 production induced by tumour
necrosis factor-α in human hepatocellular carcinoma cells. J Cell
Mol Med. 16:496–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harimoto N, Shirabe K, Abe T, Kajiyama K,
Nagaie T, Gion T, Kuroda Y and Maehara Y: Interleukin-8 producing
hepatocellular carcinoma with pyrexia. HPB Surg. 2009:4614922009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cowley S, Paterson H, Kemp P and Marshall
CJ: Activation of MAP kinase kinase is necessary and sufficient for
PC12 differentiation and for transformation of NIH 3T3 cells. Cell.
77:841–852. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mansour SJ, Matten WT, Hermann AS, Candia
JM, Rong S, Fukasawa K, Vande Woude GF and Ahn NG: Transformation
of mammalian cells by constitutively active MAP kinase kinase.
Science. 265:966–970. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmitz KJ, Wohlschlaeger J, Lang H,
Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR,
Schmid KW and Baba HA: Activation of the ERK and AKT signalling
pathway predicts poor prognosis in hepatocellular carcinoma and ERK
activation in cancer tissue is associated with hepatitis C virus
infection. J Hepatol. 48:83–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mas VR, Maluf DG, Archer KJ, Yanek K, Kong
X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P and Fisher
R: Genes involved in viral carcinogenesis and tumor initiation in
hepatitis C virus-induced hepatocellular carcinoma. Mol Med.
15:85–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kamarajah SK, Frankel TL, Sonnenday C, Cho
CS and Nathan H: Critical evaluation of the American Joint
Commission on Cancer (AJCC) 8th edition staging system for patients
with Hepatocellular Carcinoma (HCC): A surveillance, epidemiology,
end results (SEER) analysis. J Surg Onco. 117:644–650. 2018.
View Article : Google Scholar
|
|
23
|
He L, Fan X, Li Y, Chen M, Cui B, Chen G,
Dai Y, Zhou D, Hu X and Lin H: Overexpression of zinc finger
protein 384 (ZNF 384), a poor prognostic predictor, promotes cell
growth by upregulating the expression of Cyclin D1 in
Hepatocellular carcinoma. Cell Death Dis. 10:4442019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ren Y, Poon RT, Tsui HT, Chen WH, Li Z,
Lau C, Yu WC and Fan ST: Interleukin-8 serum levels in patients
with hepatocellular carcinoma: Correlations with
clinicopathological features and prognosis. Clin Cancer Res.
9:5996–6001. 2003.PubMed/NCBI
|
|
26
|
Loosen SH, Schulze-Hagen M, Leyh C, Benz
F, Vucur M, Kuhl C, Trautwein C, Tacke F, Bruners P, Roderburg C
and Luedde T: IL-6 and IL-8 serum levels predict tumor response and
overall survival after TACE for primary and secondary hepatic
malignancies. Int J Mol Sci. 19(pii): E17662018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng L, Qi Q, Wang P, Chen H, Chen Z, Meng
Z and Liu L: Serum levels of IL-6, IL-8, and IL-10 are indicators
of prognosis in pancreatic cancer. J Int Med Res. 46:5228–5236.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nacinovic-Duletic A, Stifter S, Dvornik S,
Skunca Z and Jonjic N: Correlation of serum IL-6, IL-8 and IL-10
levels with clinicopathological features and prognosis in patients
with diffuse large B-cell lymphoma. Int J Lab Hematol. 30:230–239.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakopoulou L, Mylona E, Rafailidis P,
Alexandrou P, Giannopoulou I and Keramopoulos A: Effect of
different ERK2 protein localizations on prognosis of patients with
invasive breast carcinoma. APMIS. 113:693–701. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Becher B, Spath S and Goverman J: Cytokine
networks in neuroinflammation. Nature reviews. Immunology.
17:49–59. 2017.PubMed/NCBI
|
|
31
|
Morel PA, Lee REC and Faeder JR:
Demystifying the cytokine network: Mathematical models point the
way. Cytokine. 98:115–123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu XL, Li FQ, Liu LX, Li B and Zhou ZP:
TNF-α, HGF and macrophage in peritumoural liver tissue relate to
major risk factors of HCC Recurrence. Hepatogastroenterology.
60:1121–1126. 2013.PubMed/NCBI
|
|
33
|
Peng Q, Li H, Lao X, Deng Y, Chen Z, Qin X
and Li S: Association of IL-2 polymorphisms and IL-2 serum levels
with susceptibility to HBV-related hepatocellular carcinoma in a
Chinese Zhuang population. Infect Genet Evol. 27:375–381. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pine SR, Mechanic LE, Enewold L,
Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso
NE and Harris CC: Increased levels of circulating interleukin 6,
interleukin 8, C-reactive protein, and risk of lung cancer. J Natl
Cancer Inst. 103:1112–1122. 2011. View Article : Google Scholar : PubMed/NCBI
|
